Clinical Trial

A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia

Name: A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia — clinical trial record (NCT07571928)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NOVA-NOA

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This clinical interventional study aims to assess whether treatment with with leflutrozole can improve sperm production in infertile men with non-obstructive azoospermia selected by serum anti-mullerian hormone (AMH) or Inhibin B as a positive predictive biomarker.

Trial Details

NCT Number	NCT07571928
Lead Sponsor	Martin Blomberg Jensen Collaborators: ReproNovo SA
Conditions	Infertility Due to Azoospermia, Infertility, Male
Enrollment	15 participants
Start Date	2026-05-01
Primary Completion	2027-05-31 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-06